Wound healing and protease inhibition activity of Bacoside-A, isolated from Bacopa monnieri wettest

2010 ◽  
Vol 24 (8) ◽  
pp. 1217-1222 ◽  
Author(s):  
R. Sharath ◽  
B.G. Harish ◽  
V. Krishna ◽  
B.N. Sathyanarayana ◽  
H.M. Kumara Swamy
2017 ◽  
Vol 133 (2) ◽  
pp. 203-214 ◽  
Author(s):  
J. Leonard ◽  
Bishwanath Seth ◽  
Binod B. Sahu ◽  
V. R. Singh ◽  
Nivedita Patra

2013 ◽  
Vol 35 (7) ◽  
pp. 1121-1125 ◽  
Author(s):  
Poojadevi Sharma ◽  
Sheetal Yadav ◽  
Anshu Srivastava ◽  
Neeta Shrivastava

Microbiology ◽  
2006 ◽  
Vol 152 (5) ◽  
pp. 1327-1335 ◽  
Author(s):  
Gerhard Heusipp ◽  
Katrin Spekker ◽  
Sabine Brast ◽  
Stefan Fälker ◽  
M. Alexander Schmidt

It was previously shown that α1-antitrypsin (AAT) interacts with the type III secreted (T3S) EspB and EspD proteins of enteropathogenic Escherichia coli (EPEC), resulting in reduced functionality of the proteins. To determine if AAT is also able to interact with T3S proteins of other pathogens, the binding of AAT to Yop proteins of Yersinia enterocolitica was analysed. AAT did not interact with YopB or YopD, which have functions in type III translocation similar to EspB and EspD in EPEC, but specifically interacts with YopM, a member of the leucine-rich repeat (LRR) family of proteins, in overlay and pull-down assays. To determine regions of YopM involved in AAT binding, various N- and C-terminally truncated versions of YopM were recombinantly expressed, and their ability to interact with AAT analysed. All versions tested were able to bind AAT, indicating that at least eight LRR of YopM are sufficient for AAT interaction. The main physiological role of AAT is to inhibit neutrophil elastase; however, elastase was efficiently inhibited by AAT in the presence and absence of YopM, indicating that YopM does not interfere with the anti-protease inhibition activity of AAT, and that the domain of AAT interacting with YopM is not identical to AAT's protease interaction domain. Furthermore, it was shown that elastase efficiently degrades YopM and other Yop proteins. The data suggest that AAT has additional functions in the host response against bacterial infections that are not related to its anti-protease activity.


2022 ◽  
Vol 12 (1) ◽  
Author(s):  
Smitha Chandrasekharan ◽  
Gandhimathi Chinnasamy ◽  
Somika Bhatnagar

AbstractIncrease in bacterial resistance to commonly used antibiotics is a major public health concern generating interest in novel antibacterial treatments. Aim of this scientific endeavor was to find an alternative efficient antibacterial agent from non-conventional plant source for human health applications. We used an eco-friendly approach for phyto-fabrication of silver nanoparticles (AgNPs) by utilizing logging residue from timber trees Gmelina arborea (GA). GC–MS analysis of leaves, barks, flowers, fruits, and roots was conducted to determine the bioactive compounds. Biosynthesis, morphological and structural characterization of GA-AgNPs were undertaken by UV–Vis spectroscopy, scanning electron microscopy (SEM), energy-dispersive spectroscopy (EDX), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR) and X-ray diffractometer (XRD). GA-AgNPs were evaluated for antibacterial, antibiofilm, antioxidant, wound healing properties and their toxicity studies were carried out. Results identified the presence of terpenoids, sterols, aliphatic alcohols, aldehydes, and flavonoids in leaves, making leaf extract the ideal choice for phyto-fabrication of silver nanoparticles. The synthesis of GA-AgNPs was confirmed by dark brown colored colloidal solution and spectral absorption peak at 420 nm. Spherical, uniformly dispersed, crystalline GA-AgNPs were 34–40 nm in diameter and stable in solutions at room temperature. Functional groups attributed to the presence of flavonoids, terpenoids, and phenols that acted as reducing and capping agents. Antibacterial potency was confirmed against pathogenic bacteria Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus by disc diffusion assay, MIC and MBC assay, biofilm inhibition assay, electron-microscopy, cell staining and colony counting techniques. The results from zone of inhibition, number of ruptured cells and dead-cell-count analysis confirmed that GA-AgNPs were more effective than GA-extract and their bacteria inhibition activity level increased further when loaded on hydrogel as GA-AgNPs-PF127, making it a novel distinguishing feature. Antioxidant activity was confirmed by the free radical scavenging assays (DPPH and ABTS). Wound healing potential was confirmed by cell scratch assay in human dermal fibroblast cell lines. Cell-proliferation study in human chang liver cell lines and optical microscopic observations confirmed non-toxicity of GA-AgNPs at low doses. Our study concluded that biosynthesized GA-AgNPs had enhanced antibacterial, antibiofilm, antioxidant, and wound healing properties.


2017 ◽  
Vol 98 ◽  
pp. 76-81 ◽  
Author(s):  
Cinthya Christopher ◽  
Anil John Johnson ◽  
Paravanparampil Jacob Mathew ◽  
Sabulal Baby

2019 ◽  
Vol 57 (10) ◽  
pp. 920-930 ◽  
Author(s):  
Sunayna Choudhary ◽  
Indu Pal Kaur ◽  
Jai Malik

Abstract The use of herbs as medicine is an ancient form of healthcare known to mankind. Standardization of herbal medicines is however a challenging task and is the major bottleneck in their acceptance as the primary therapeutic option. The aim of this study was to develop and validate a simple, rapid HPLC method for standardizing the mixture of extracts of three Medhya Rasayanas (neurotonic), Convolvulus pluricaulis, Withania somnifera and Bacopa monnieri. Simultaneous estimation of the respective bioactive markers of these plants viz., scopoletin, withaferin A, bacoside A 3, bacopaside II, jujubogenin and bacosaponin C has been reported for the first time. The method was developed using Waters Hybrid X-Bridge shield with BEH technology 2.5 μm, 4.6 × 75 mm column and validated according to ICH guidelines. The 20 minutes run time makes the method eco-friendly. The method was linear over a range of 12.5–400 ng/10 μL for scopoletin and 62.5–2,000 ng/10 μL for withaferin A, bacoside A 3, bacopaside II, jujubogenin and bacosaponin C with detection limits of 8.0, 48.3, 30.4, 40.7, 15.6 and 18.9 ng/10 μL and quantification limits of 24.5, 146.5, 92.2, 123.4, 47.4 and 57.4 ng/10 μL, respectively. The correlation coefficient for each analyte was >0.999. The intra-day and inter-day precision was <2%. These results confirmed the precision, accuracy and robustness of the proposed method.


Fitoterapia ◽  
2010 ◽  
Vol 81 (5) ◽  
pp. 315-322 ◽  
Author(s):  
Jobin Mathew ◽  
Jes Paul ◽  
M.S. Nandhu ◽  
C.S. Paulose

Sign in / Sign up

Export Citation Format

Share Document